Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
4AT (Rapid Assessment Test for Delirium)ACS-NSQIP Surgical Risk CalculatorAD8 Dementia ScreeningAnticholinergic Burden Score (ACB)Barthel IndexBeers Criteria (PIMs)Berg Balance ScaleBraden ScaleCAM — Confusion Assessment MethodClinical Dementia Rating (CDR)Clinical Frailty Scale (CFS)Clock Drawing Test (CDT)Cornell Scale for Depression (CSDD)DOSS (Delirium Observation Screening Scale)DRS-R-98 (Delirium Rating Scale)Drug Burden Index (DBI)Edmonton Frail Scale (EFS)FRAIL ScaleFried Frailty PhenotypeFunctional Independence Measure (FIM)Functional Reach TestGeriatric Depression Scale (GDS-15)Groningen Frailty Indicator (GFI)HELP Score (Postoperative Delirium Risk)Hendrich II Fall Risk ModelICIQ-UI SFinterRAI Clinical AssessmentIQCODEKatz Index of Independence in ADLsLawton Instrumental ADL ScalemFI-5 Preoperative FrailtyMini Nutritional Assessment (MNA) - FullMini-CogMMSEMNA-SF (Short Form)Morse Fall ScaleMUST (Malnutrition Universal Screening Tool)Norton ScaleOAB-V8OST (Osteoporosis Screening Tool)OSTA (Osteoporosis Self-Assessment Tool for Asians)Six-Item Screener (SIS)SPMSQSTOPP/START CriteriaSTRATIFY Risk Assessment ToolTimed Up and Go (TUG) TestTriage Risk Screening Tool (TRST)Waterlow Score
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

DiabetologiaJun 9, 2026
Fetal growth is driven by a bimodal fetal beta cell response and reshaped by a ketogenic diet in a mouse model of maternal diabetes

Clinical Context

We think this has broad domain relevance to OABV 8.

DiabetologiaJun 9, 2026
Unravelling the developmental origins of cystic fibrosis-related diabetes

Clinical Context

We think this has broad domain relevance to OABV 8.

DiabetologiaJun 8, 2026
Genetics of MASLD: a diabetes perspective

Clinical Context

We think this has broad domain relevance to OABV 8.

OAB-V8

OAB-V8: Ask the patient: "How bothered were you by the following symptoms over the past 4 weeks?"

Rate 8 Symptoms

1. Frequent urination during the daytime hours?

2. An uncomfortable urge to urinate?

3. A sudden urge to urinate with little or no warning?

4. Accidental loss of small amounts of urine?

5. Nighttime urination?

6. Waking up at night because you had to urinate?

7. A strong urge to urinate?

8. Urine loss associated with a strong desire to urinate?

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

Screening older adults for Overactive Bladder (OAB) syndrome in primary care.
Assessing the degree of bother caused by urinary urgency, frequency, and nocturia.
Guiding the initiation of anticholinergics or beta-3 agonists.
Monitoring symptom improvement after starting pharmacotherapy.

The "Bother" Metric

Overactive bladder is fundamentally a symptom-driven diagnosis. The OAB-V8 does not ask how many milliliters a patient voids; it asks how much the symptoms *bother* the patient, which is the true driver for prescribing medications in geriatrics.

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the ICIQ-UI SF to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Geriatrics Tools

Waterlow Score
SPMSQ
Beers Criteria
Lawton Instrumental ADL Scale
Hendrich II Fall Risk Model
ICIQ-UI SF
CAM — Confusion Assessment Method
Clock Drawing Test
DOSS
Mini-Cog
Geriatrics CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.